ISPOR council to raise patient voice in healthcare research, decision making
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recently established a new advisory council devoted to patient engagement.
Archives for January 15, 2018
New trial design guidelines address ‘inappropriate’ patient exclusion
Exclusion of brain metastasis patients from clinical trials of anti-cancer drugs could remove up to two-thirds of the stage IV population, say researchers who have published new guidelines aimed at bringing attention to opportunities for improvement.
UPDATE
Mundipharma to distribute Grünenthal’s pain-relief drug in China
German firm Grünenthal has signed a license and distribution deal with Mundipharma for the former’s analgesic Tramal (tramadol).
Australia bans over-the-counter codeine sales to target opioid abuse
Australia’s Therapeutic Goods Administration will reclassify all codeine products to ‘prescription only’ from February 1, in a bid to combat opioid tolerance, dependence and poisoning.
news in brief
MedPharm launches new topical formulation testing technologies
MedPharm has launched automated testing systems for topical formulations it claims can help developers cut timelines.
Brexit bad for orphans: Concerns about cost to rare disease-focused UK pharma
Eurodis says Brexit-related costs and admin burden placed on UK pharma may affect availability of drugs for rare diseases and discourage development of such products.
Aviragen Vaxart merger to create $264m tablet vaccine firm
Aviragen Therapeutics has called on shareholders to back its proposed merger with oral vaccine delivery firm Vaxart.